Senzime to Present at the European Growth Virtual Investor Conference on September 11
Uppsala, Sweden – September 8, 2025 – Senzime AB (Nasdaq Stockholm: SEZI; US OTCQX: SNZZF), a leader in precision-based monitoring of patients undergoing anesthesia, today announced that Philip Siberg, CEO of Senzime, has been selected to present at the European Growth Virtual Investor Conference on September 11, 2025.
Date: September 11, 2025
Time: 10:00 a.m. ET / 16:00 CET
Link: Conference Registration & Access (see also link below)
This will be a live, interactive online event where investors are invited to ask the company questions in real time. For those unable to attend the live session, an archived webcast will be available following the event. Investors are encouraged to pre-register and run a system check to ensure smooth participation and to receive event updates. For more information about the event, visit www.virtualinvestorconferences.com.
Link to registration: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5070809/senzime-ab-otcqx-snzzf-nasdaq-stockholm-sezi
Contact
Philip Siberg, CEO of Senzime
+46 (0) 70 790 6734
[email protected]